Newton BioCapital
Overview
Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.
Investment Focus
- Focus on chronic diseases
- Early-stage biotech and life science projects
- Projects in Europe and Japan
Portfolio Companies
Reach Newton BioCapital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Newton BioCapital
What sectors does Newton BioCapital invest in?
Newton BioCapital invests in Healthcare, Life Sciences and Biotechnology, and is based in Woluwe-Saint-Pierre, Belgium. Newton BioCapital is listed as a vc in the ConnectSafely investor database.
What stage does Newton BioCapital invest at?
Newton BioCapital backs companies at Seed, Early Stage, Series A, Series B and Growth, writing cheques of 1M - 50M.
Which regions does Newton BioCapital invest in?
Newton BioCapital invests across Germany, Japan, France, Netherlands and Belgium.
Who are the partners at Newton BioCapital?
Team members listed for Newton BioCapital include Guy Heynen (Chief Medical Officer and CRO) and Dario Padovani (CFO & Administrative advisor).
What companies has Newton BioCapital invested in?
Newton BioCapital's portfolio includes DeuterOncology, NeuVasQ Biotechnologies and Epics Therapeutics.
How do I contact Newton BioCapital?
Newton BioCapital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
